潍坊医学院学报
濰坊醫學院學報
유방의학원학보
JOURNAL OF WEIFANG MEDICAL COLLEGE
2013年
5期
324-327
,共4页
崔娟娟%陈娟%赵桂云%冯占芹%郑增娟%张维芬
崔娟娟%陳娟%趙桂雲%馮佔芹%鄭增娟%張維芬
최연연%진연%조계운%풍점근%정증연%장유분
壳聚糖%氨茶碱%喷雾干燥法%微球%肺部给药
殼聚糖%氨茶堿%噴霧榦燥法%微毬%肺部給藥
각취당%안다감%분무간조법%미구%폐부급약
Chitosan%Theophylline%Spray drying%Microsphere%Pulmonary delivery
目的:制备氨茶碱/壳聚糖/β-环糊精肺吸入缓释微球,考察其特性。方法采用喷雾干燥法制备3种不同药物/载体比例的茶碱/壳聚糖/β-环糊精微球A,B,C,通过扫描电镜、激光粒度测定仪、红外光谱仪表征其理化性质,透析法研究其体外释放行为。结果最佳药物/载体比例( TH∶CTS∶β-CD)为1∶3∶1;扫描电镜结果显示微球外观圆整,表面光滑或有皱折;微球A,B,C 50%的容积粒径为(4.97±0.03)μm,(4.90±0.45)μm,(6.43±0.08)μm,分布范围窄;载药量为35.70%±0.09%,21.09%±0.62%,13.33%±0.33%;包封率为88.79%±0.23%,91.40%±2.71%,85.16%±2.15%;产率为52.98%±1.05%,46.08%±0.13%,45.81%±0.04%;红外光谱结果显示茶碱与壳聚糖和β-环糊精高分子间发生氢键反应;体外释放结果证实茶碱/壳聚糖/β-环糊精微球具有缓释作用,并且与药物/载体比例及药物性质有关。结论喷雾干燥法能成功制备氨茶碱/壳聚糖/β-环糊精缓释微球,符合肺吸入粉雾剂的各项要求,该微球有望成为肺部给药的良好载体。
目的:製備氨茶堿/殼聚糖/β-環糊精肺吸入緩釋微毬,攷察其特性。方法採用噴霧榦燥法製備3種不同藥物/載體比例的茶堿/殼聚糖/β-環糊精微毬A,B,C,通過掃描電鏡、激光粒度測定儀、紅外光譜儀錶徵其理化性質,透析法研究其體外釋放行為。結果最佳藥物/載體比例( TH∶CTS∶β-CD)為1∶3∶1;掃描電鏡結果顯示微毬外觀圓整,錶麵光滑或有皺摺;微毬A,B,C 50%的容積粒徑為(4.97±0.03)μm,(4.90±0.45)μm,(6.43±0.08)μm,分佈範圍窄;載藥量為35.70%±0.09%,21.09%±0.62%,13.33%±0.33%;包封率為88.79%±0.23%,91.40%±2.71%,85.16%±2.15%;產率為52.98%±1.05%,46.08%±0.13%,45.81%±0.04%;紅外光譜結果顯示茶堿與殼聚糖和β-環糊精高分子間髮生氫鍵反應;體外釋放結果證實茶堿/殼聚糖/β-環糊精微毬具有緩釋作用,併且與藥物/載體比例及藥物性質有關。結論噴霧榦燥法能成功製備氨茶堿/殼聚糖/β-環糊精緩釋微毬,符閤肺吸入粉霧劑的各項要求,該微毬有望成為肺部給藥的良好載體。
목적:제비안다감/각취당/β-배호정폐흡입완석미구,고찰기특성。방법채용분무간조법제비3충불동약물/재체비례적다감/각취당/β-배호정미구A,B,C,통과소묘전경、격광립도측정의、홍외광보의표정기이화성질,투석법연구기체외석방행위。결과최가약물/재체비례( TH∶CTS∶β-CD)위1∶3∶1;소묘전경결과현시미구외관원정,표면광활혹유추절;미구A,B,C 50%적용적립경위(4.97±0.03)μm,(4.90±0.45)μm,(6.43±0.08)μm,분포범위착;재약량위35.70%±0.09%,21.09%±0.62%,13.33%±0.33%;포봉솔위88.79%±0.23%,91.40%±2.71%,85.16%±2.15%;산솔위52.98%±1.05%,46.08%±0.13%,45.81%±0.04%;홍외광보결과현시다감여각취당화β-배호정고분자간발생경건반응;체외석방결과증실다감/각취당/β-배호정미구구유완석작용,병차여약물/재체비례급약물성질유관。결론분무간조법능성공제비안다감/각취당/β-배호정완석미구,부합폐흡입분무제적각항요구,해미구유망성위폐부급약적량호재체。
Objective The objective of this study is to prepare the inhalation sustained-release microspheres of TH/CTS/β-CD and probe into their properties .Methods The three different ratios of TH/CTS/β-CD were prepared by spray drying method .The characteris-tics of TH/CTS/β-CD microspheres were carried out by Scanning Electron Microscopy (SEM),Laser diffraction,Fourier Transform Infrared Spectroscope(FT-IR).Dialysis method was used to study the release behavior in vitro .Results The optimal ratio of drug/carrier(TH:CTS:β-CD) was 1∶3∶1.It showed that the preparations were spherical microspheres with smooth or slightly wrinkled surfaces by SEM .Fifty per-cent of volume diameter were 4.97μm ±0.03μm,4.90μm ±0.45μm,6.43μm ±0.08μm on microspheres A,B,C.The microspheres had a narrower particle size distribution and could meet the requirements of powder for inhalation on particle size .The drug loading were 35.70%± 0.09%,21.09%±0.62%and 13.33%±0.33%.The encapsulation efficiencies were 88.79%±0.23%,91.40%±2.71%and 85.16%±2.51%.The yield of microspheres A ,B,C were 52.98%±1.05%,46.08%±0.13%,45.81%±0.04%.FT-IR spectroscopy revealed that hydrogen bonds were formed between TH and CTS or β-CD.The release content of TH from microspheres was slower at pH 6.8 in vitro and it was related to the ratio of drug/polymer.Conclusion TH/CTS/β-CD microspheres can successfully be prepared by spray drying method and it will be an ideal drug carrier which is used in pulmonary delivery system .